Invesaro

Stocks Comparison

Antiaging Quantum Living vs Harte Hanks: revenue, profit, margins and growth compared

Antiaging Quantum Living brought in $1M of revenue in fiscal 2026, Harte Hanks $159.6M in fiscal 2025. Revenue changed by +26.5% at Antiaging Quantum Living and -13.9% at Harte Hanks on the year before, so Antiaging Quantum Living grew faster. Antiaging Quantum Living kept -81.0% of its revenue as net profit, Harte Hanks -0.5%.

Side by side, latest fiscal year

AAQLHHS
Fiscal year endedFY2026 (March 31, 2026)FY2025 (December 31, 2025)
Revenue$1M$159.6M
Revenue growth+26.5%-13.9%
Net income-$837.6K-$811K
Net margin-81.0%-0.5%
Free cash flown/a-$4.5M
Free cash flow marginn/a-2.8%
Earnings per share (diluted)-$0.03-$0.11
Cash$503.5K$5.6M
Debtn/an/a
Price to earningsn/an/a
Market value$19.9M$34.3M
Dividend yieldn/an/a
Rank by revenue in sector#1018 of 1065 · Consumer discretionary#726 of 1065 · Consumer discretionary

Over the years

Revenue
AAQL FY2021: $3.8KAAQL FY2022: $7.4KAAQL FY2023: $13.6KAAQL FY2024: $7.5KAAQL FY2025: $817.9KAAQL FY2026: $1MHHS FY2018: $284.6MHHS FY2019: $217.6MHHS FY2020: $176.9MHHS FY2021: $194.6MHHS FY2022: $206.3MHHS FY2023: $191.5MHHS FY2024: $185.2MHHS FY2025: $159.6MFY18FY19FY20FY21FY22FY23FY24FY25FY26
AAQL $1MHHS $159.6M
Net income
AAQL FY2019: -$70.5KAAQL FY2020: -$59.1KAAQL FY2021: -$66.5KAAQL FY2022: -$43.4KAAQL FY2023: -$36.6KAAQL FY2024: -$413KAAQL FY2025: -$720.4KAAQL FY2026: -$837.6KHHS FY2018: $17.6MHHS FY2019: -$26.3MHHS FY2020: -$1.7MHHS FY2021: $15MHHS FY2022: $36.8MHHS FY2023: -$1.6MHHS FY2024: -$30.3MHHS FY2025: -$811KFY18FY19FY20FY21FY22FY23FY24FY25FY26
AAQL -$837.6KHHS -$811K
Net margin
AAQL FY2021: -1,750.3%AAQL FY2022: -587.0%AAQL FY2023: -269.3%AAQL FY2024: -5,507.0%AAQL FY2025: -88.1%AAQL FY2026: -81.0%HHS FY2018: 6.2%HHS FY2019: -12.1%HHS FY2020: -1.0%HHS FY2021: 7.7%HHS FY2022: 17.8%HHS FY2023: -0.8%HHS FY2024: -16.4%HHS FY2025: -0.5%FY18FY19FY20FY21FY22FY23FY24FY25FY26
AAQL -81.0%HHS -0.5%
Revenue growth
AAQL FY2022: +94.7%AAQL FY2023: +83.8%AAQL FY2024: -44.9%AAQL FY2025: +10,806.8%AAQL FY2026: +26.5%HHS FY2019: -23.6%HHS FY2020: -18.7%HHS FY2021: +10.0%HHS FY2022: +6.0%HHS FY2023: -7.2%HHS FY2024: -3.3%HHS FY2025: -13.9%FY19FY20FY21FY22FY23FY24FY25FY26
AAQL +26.5%HHS -13.9%
Free cash flow
AAQL FY2022: -$42.1KHHS FY2018: -$13.4MHHS FY2019: $9.2MHHS FY2020: -$10.5MHHS FY2021: -$4.8MHHS FY2022: $23MHHS FY2023: $7.7MHHS FY2024: -$6.7MHHS FY2025: -$4.5MFY18FY19FY20FY21FY22FY23FY24FY25
AAQL -$42.1KHHS -$4.5M

Fiscal years as each company reports them; the two may end in different months.

Questions about Antiaging Quantum Living and Harte Hanks

Which is bigger by revenue, Antiaging Quantum Living or Harte Hanks?

Harte Hanks is bigger by revenue: $159.6M in fiscal 2025, against $1M for Antiaging Quantum Living in fiscal 2026.

Which keeps more of its revenue as profit, Antiaging Quantum Living or Harte Hanks?

Antiaging Quantum Living had a net margin of -81.0% in fiscal 2026; Harte Hanks had -0.5% in fiscal 2025.

Which grew revenue faster, Antiaging Quantum Living or Harte Hanks?

In their latest fiscal years revenue changed by +26.5% at Antiaging Quantum Living and -13.9% at Harte Hanks.

Where do these numbers come from?

From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.

Compare more companies